A mitochondrial SCF‐FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease

Yu Cao,Jing Zheng,Huayun Wan,Yuqiu Sun,Song Fu,Shanshan Liu,Baiyu He,Gaihong Cai,Yang Cao,Huanwei Huang,Qi Li,Yan Ma,She Chen,Fengchao Wang,Hui Jiang

DOI: https://doi.org/10.15252/embj.2022113033

2023-03-12

The EMBO Journal

Abstract:Mice lacking disease‐mutated FBXL4 exhibit loss of mitochondria and perinatal lethality due to excessive basal mitophagy. Mitophagy is a fundamental quality control mechanism of mitochondria. Its regulatory mechanisms and pathological implications remain poorly understood. Here, via a mitochondria‐targeted genetic screen, we found that knockout (KO) of FBXL4, a mitochondrial disease gene, hyperactivates mitophagy at basal conditions. Subsequent counter screen revealed that FBXL4‐KO hyperactivates mitophagy via two mitophagy receptors BNIP3 and NIX. We determined that FBXL4 functions as an integral outer‐membrane protein that forms an SCF‐FBXL4 ubiquitin E3 ligase complex. SCF‐FBXL4 ubiquitinates BNIP3 and NIX to target them for degradation. Pathogenic FBXL4 mutations disrupt SCF‐FBXL4 assembly and impair substrate degradation. Fbxl4−/− mice exhibit elevated BNIP3 and NIX proteins, hyperactive mitophagy, and perinatal lethality. Importantly, knockout of either Bnip3 or Nix rescues metabolic derangements and viability of the Fbxl4−/− mice. Together, beyond identifying SCF‐FBXL4 as a novel mitochondrial ubiquitin E3 ligase restraining basal mitophagy, our results reveal hyperactivated mitophagy as a cause of mitochondrial disease and suggest therapeutic strategies.